Several groups, including our own have demonstrated, using autoradiography approaches in postmortem brain tissue samples, that [18F]-AV-1451 has a significantly higher affinity for tau aggregates in the form of NFTs in AD compared to tau aggregates in non-AD tauopathies [19–21, 33]. The gene discussed is MAPT; the disease is Alzheimer disease.